Prostate Diffusion Imaging With Distortion Correction
Conditions: Prostate Cancer Interventions: Diagnostic Test: MRI scan Sponsors: Norfolk and Norwich University Hospitals NHS Foundation Trust; University of East Anglia Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Choices About Genetic Testing And Learning Your Risk With Smart Technology
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer; Pancreas Cancer; Colorectal Cancer; Endometrial Cancer; Prostate Cancer Interventions: Device: Relational Agent; Other: Clinical Letter Sponsors: Rutgers, The State University of New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Prostatic Size Reduction Following of Leuprorelin Acetate
Conditions: Prostate Cancer Adenocarcinoma; Prostate Adenocarcinoma Interventions: Other: ACETATE LEUPRELINE Sponsors: Consorci Sanitari de Terrassa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection
Conditions: PROSTATE CANCER; Prostate Biopsy Interventions: Diagnostic Test: Prostate imaging; Procedure: Prostate biopsy Sponsors: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
First patient dosed in Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
SYDNEY, Dec. 22, 2023. Clarity Pharmaceuticals (ASX: CU6) ( " Clarity " ), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 22, 2023 Category: Pharmaceuticals Source Type: clinical trials
11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.
Conditions: Prostate Cancer Interventions: Diagnostic Test: 11C-choline PET/CT Sponsors: IRCCS San Raffaele Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
Conditions: Localized Prostate Carcinoma; Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8 Interventions: Procedure: Cryosurgery; Procedure: High-Intensity Focused Ultrasound Ablation; Other: Survey Administration Sponsors: Marc Dall ' Era, MD; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Conditions: Metastatic Prostate Cancer; Intermitent Anti-androgen Therapy Interventions: Drug: Darolutamide continuous; Drug: Darolutamide intermittent Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL
Conditions: Prostate Cancer Interventions: Radiation: MR Linac delivered Radiotherapy Sponsors: Sunnybrook Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial
This study will confirm in humans the pharmacodynamic effect of AR ligands to induce transient double-strand breaks when administered in the context of androgen deprivation as a novel therapy for prostate cancer. The findings of this study will permit the development of a larger trial evaluating flutamide pulsed-dose sequencing in association with fractionated external beam RT (+/ − brachytherapy). The study is ongoing, and preliminary data collection and recruitment are underway; analysis has yet to be performed.Trial registrationClinicalTrials.gov NCT03507608. Prospectively registered on 25 April 2018. (Source: Trials)
Source: Trials - December 16, 2023 Category: Research Source Type: clinical trials
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
Conditions: Advanced Prostate Adenocarcinoma; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8 Interventions: Drug: Abiraterone; Procedure: Biospecimen Collection; Drug: Darolutamide; Drug: Prednisone Sponsors: Mamta Parikh; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Conditions: Prostate Cancer Interventions: Other: Intermittent Fasting Sponsors: State University of New York at Buffalo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
Conditions: Prostate Cancer Interventions: Radiation: Radiation; Radiation: MRI; Other: Androgen Deprivation Therapy Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?
Conditions: Prostate Cancer Interventions: Diagnostic Test: Diagnostic accuracy Sponsors: IRCCS San Raffaele Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Conditions: Prostate Cancer; Prostate Cancer Metastatic Interventions: Other: Counseling Tool; Other: Questionnaires Sponsors: University of California, San Francisco; Prostate Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
